Dexmedetomidine sedation in ICU
Dexmedetomidine (DEX), a highly selective α2-adrenergic receptor agonist, is the newest agent introduced for sedation in intensive care unit (ICU). The sedation strategy for critically ill patients has stressed light sedation with daily awakening and assessment for neurologic, cognitive, and respira...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Anesthesiologists
2012-05-01
|
Series: | Korean Journal of Anesthesiology |
Subjects: | |
Online Access: | http://ekja.org/upload/pdf/kjae-62-405.pdf |